Literature DB >> 16413617

Indications for surgery in acute mastoiditis and their complications in children.

Diego Zanetti1, Nader Nassif.   

Abstract

OBJECTIVE: To review the clinical charts of 45 paediatric patients treated for acute otomastoiditis at the ORL Department of the University of Brescia (Italy) between January 1994 and March 2005 and to discuss the diagnostic workup and the outcome of treatment.
METHODS: Twenty-six males and 19 females were admitted with acute mastoiditis and subperiosteal abscess. Thirteen of them (28.9%) presented an intracranial complication. Only three of them were not operated upon; one received a ventilation tube (VT); all the others underwent a mastoidectomy within 48-72 h. Twenty out of 32 uncomplicated mastoiditis were treated conservatively and the remaining 12 underwent myringotomy+/-VT, associated with a mastoidectomy in 9 cases.
RESULTS: Antibiotics alone or with VTs achieved a full recovery in 28 out of 32 uncomplicated cases. Mastoidectomy resolved the disease in 13 patients (9 with complications). In severe complications, a canal wall down (CWD) (n=2) or an intact canal wall (ICW) mastoidectomy (n=7) were preferred, based on the extent of the lesions and the degree of hearing loss. All children recovered completely at 1 year follow-up. In the uncomplicated cases that were operated upon, the mean hospital stay was 7.8 days (versus 4.3 days for the conservative group). In children with intracranial complications the mean hospital stay was 12.8 days, significantly less than the four non-surgical patients, who remained hospitalized for an average of 18 days.
CONCLUSION: Acute mastoiditis can fully recover with conservative treatment or myringotomy+VTs. Immediate surgical treatment is indicated for intracranial complications, if the neurological conditions are not critical. A simple mastoidectomy+/-tympanoplasty is warranted in: (1) exteriorization, if the child is older than 30 months or >15 kg of weight, (2) intracranial complications (combined with a neurosurgical procedure as needed) and (3) cholesteatoma or granulation tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413617     DOI: 10.1016/j.ijporl.2005.12.002

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  8 in total

1.  Challenges in the management of acute mastoiditis in children.

Authors:  Sofia Kordeluk; Mordechai Kraus; Eugene Leibovitz
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

2.  Mastoiditis in adults: a 19-year retrospective study.

Authors:  S Palma; R Bovo; A Benatti; C Aimoni; M Rosignoli; M Libanore; A Martini
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-16       Impact factor: 2.503

Review 3.  Current concepts in the pathogenesis and treatment of chronic suppurative otitis media.

Authors:  Rahul Mittal; Christopher V Lisi; Robert Gerring; Jeenu Mittal; Kalai Mathee; Giri Narasimhan; Rajeev K Azad; Qi Yao; M'hamed Grati; Denise Yan; Adrien A Eshraghi; Simon I Angeli; Fred F Telischi; Xue-Zhong Liu
Journal:  J Med Microbiol       Date:  2015-08-05       Impact factor: 2.472

Review 4.  Diseases of the middle ear in childhood.

Authors:  Amir Minovi; Stefan Dazert
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2014-12-01

5.  Bacterial meningitis complicated by cerebral venous thrombosis.

Authors:  Shahrzad S Deliran; Matthijs C Brouwer; Jonathan M Coutinho; Diederik van de Beek
Journal:  Eur Stroke J       Date:  2020-11-11

Review 6.  What is new in otitis media?

Authors:  Lucien Corbeel
Journal:  Eur J Pediatr       Date:  2007-03-16       Impact factor: 3.183

7.  Two cases of acute mastoiditis with subperiosteal abscess.

Authors:  Sung Ryeal Kim; Oak-Sung Choo; Hun Yi Park
Journal:  Korean J Audiol       Date:  2013-09-24

8.  Therapeutic approach to pediatric acute mastoiditis - an update.

Authors:  Józef Mierzwiński; Justyna Tyra; Karolina Haber; Maria Drela; Dariusz Paczkowski; Michael David Puricelli; Anna Sinkiewicz
Journal:  Braz J Otorhinolaryngol       Date:  2018-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.